Capivasertib - AstraZeneca
At a glance
- Drug Originator Astex Therapeutics; Cancer Research Technology; The Institute of Cancer Research
- Drug Licenced by AstraZeneca
- Drug Class Antineoplastics; Piperidines; Pyrimidines; Pyrroles; Small molecules
- Mechanism of Action Proto-oncogene protein c-akt inhibitors
- USA Patent Applicants ASTRAZENECA
- USA Patents 11
- NDAs 1
- International Patents 92
- Patent Applications 351
Table of Contents
Disclaimer